Matrix metalloproteinase-9 and cell division in neuroblastoma cells and bone marrow macrophages

American Journal of Pathology

Volumn 177, Issue 6, 2010, Pages 2870-2885

  Gloria Sans Fons, M ^a   Sole, Sonia ^a   Sanfeliu, Coral ^a   Planas, Anna M ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GELATINASE INHIBITOR; RECOMBINANT ENZYME; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CYCLE ARREST; CELL DIVISION; CELL GROWTH; CELL NUCLEUS; CHROMATID; CHROMOSOME SEGREGATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MACROPHAGE; MICROTUBULE; MITOSIS; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 78650216761     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090050     Document Type: Article

References (43)

1. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE: Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci USA 1990, 87:364-368 (Pubitemid 20033071)
2. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991, 5:2145-2154
3. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR: Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998, 21:75-80
4. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990, 9:289-303
5. Tonn JC, Kerkau S, Hanke A, Bouterfa H, Mueller JG, Wagner S, Vince GH, Roosen K: Effect of synthetic matrix-metalloproteinase inhibitors of invasive capacity and proliferation of human malignant gliomas in vitro. Int J Cancer 1999, 80:764-772
6. Rabbani SA, Harakidas P, Guo Y, Steinman D, Davidsen SK, Morgan DW: Synthetic inhibitor of matrix metalloproteases decreases tumor growth and metastases in a synergic model of rat prostate cancer in vivo. Int J Cancer 2000, 87:276-282
7. Yamashita T, Fujii M, Tomita T, Ishiguro R, Tashiro M, Tokumaru Y, Imanishi Y, Kanke M, Ogawa K, Kameyama K, Otani Y: The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma. Anticancer Res 2003, 23:2297-2302 (Pubitemid 36897094)
8. Moon SK, Cha BY, Kim CH: In vitro cellular aging is associated with enhanced proliferative capacity. G1 cell cycle modulation, and matrix metalloproteinase-9 regulation in mouse aortic smooth muscle cells. Arch Biochem Biophys 2003, 418:39-48
9. Aoudjit F, Masure S, Opdenakker G, Potworowski E, St-Pierre Y: Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma. Int J Cancer 1999, 82:743-747 (Pubitemid 29356975)
10. Rooprai HK, Rucklidge GJ, Panou C, Pilkington GJ: The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 2000, 82:52-55
11. Miettinen PJ, Chin JR, Shum L, Slavkin HC, Shuler CF, Derynck R, Werb Z: Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet 1999, 22:69-73
12. Kondapaka SB, Fridman R, Reddy KB: Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int J Cancer 1997, 70:722-726
13. Visscher DW, Sarkar FH, Kasunic TC, Reddy KB: Clinicopathologic analysis of amphiregulin and heuregulin immunostaining in breast neoplasia. Breast Cancer Res Treat 1997, 45:75-80
14. O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA: Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Res 2000, 60:1121-1128 (Pubitemid 30129555)
15. Reddy KB, Krueger JS, Kondapaka SB, Diglio CA: Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer 1999, 82:268-273
16. O-charoenrat P, Rhys-Evans P, Court WJ, Box GM, Eccles SA: Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erb B ligands. Clin Exp Metastasis 1999, 17:631-639 (Pubitemid 30337138)
17. Massague J: Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J Biol Chem 1983, 258:13614-13620
18. Derynck R: Transforming growth factor-α. Cell 1988, 54:593-595
19. Ueda M, Ueki M, Terai Y: Morimoto A. Fujii H, Yoshizawa K, Yanagihara T: stimulatory effects of EGF and TGF-α on invasive activity and 5′-deoxy-5-fluorouridine sensitivity in uterine cervical-carcinoma SKG-IIIb cells. Int J Cancer 1997, 72:1027-1033
20. Golubkov VS, Boyd S, Savinov AY, Chekanov AV, Osterman AL, Remacle A, Rozanov DV, Doxsey SJ, Strongin AY: Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability. J Biol Chem 2005, 280:25079-25086 (Pubitemid 40934599)
21. Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G, Schulz R: Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J 2004, 18:690-692
22. Valledor AF, Arpa L, Sánchez-Tilló E, Comalada M, Casals C, Xaus J, Caelles C, Lloberas J, Celada A: IFN-γ-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation. Blood 2008, 112:3274-3282
23. Zhang JW, Gottschall PE: Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods 1997, 76:15-20
24. Planas AM, Solé S, Justicia C, Rodríguez-Farré E: Estimation of gelatinase content in rat brain: effect of focal ischemia. Biochem Biophys Res Commun 2000, 278:803-807
25. Planas AM, Solé S, Justicia C: Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 2001, 8:834-846 (Pubitemid 33055599)
26. Planas AM, Justicia C, Solé S, Friguls B, Cervera A, Adell A, Chamorro A: Certain forms of matrix metalloproteinase-9 accumulate in the extracellular space after microdialysis probe implantation and middle cerebral artery occlusion/reperfusion. J Cereb Blood Flow Metab 2002, 22:918-925
27. Limb GA, Matter K, Murphy G, Cambrey AD, Bishop PN, Morris GE, Khaw PT: Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis. Am J Pathol 2005, 166:1555-1563
28. Wang W, Schulze, CJ, Suarez-Pinzon WL, Dyck JRB, Sawicki G, Schulz R: Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 2002, 106:1543-1549
29. Pérez-Martínez L, Jaworski DM: Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitotic signal. J Neurosci 2005, 25:4917-4929
30. Ip YC, Cheung ST, Fan ST: Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma. Mol Carcinog 2007, 46:225-230
31. Si-Tayeb K, Monvoisin A, Mazzocco C, Lepreux S, Decossas M, Cubel G, Taras D, Blanc JF, Robinson DR, Rosenbaum J: Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 2006, 169:1390-401
32. Gönczy P: Nuclear envelope: torn apart at mitosis. Curr Biol 2002, 12:R242-244
33. Loidl P, Eberharter A: Nuclear matrix and the cell cycle. Int Rev Cytol 1995, 162B:377-403
34. Bosman FT: The nuclear matrix in pathology. Virchows Arch 1999, 435:391-399
35. Goldberg M, Harel A, Gruenbaum Y: The nuclear lamina: molecular organization and interaction with chromatin. Crit Rev Eukaryot Gene Expr 1999, 9:285-293 (Pubitemid 30053881)
36. Gotzmann J, Foisner R: Lamins and lamin-binding proteins in functional chromatin organization. Crit Rev Eukaryot Gene Expr 1999, 9:257-265
37. Ottaviano Y, Gerace L: Phosphorylation of the nuclear lamins during interphase and mitosis. J Biol Chem 1985, 260:624-632
38. Nickerson JA: Nuclear dreams: the malignant alteration of nuclear architecture. J Cell Biochem 1998, 70:172-180
39. Biggins S, Murray AW: Sister chromatid cohesion in mitosis. Curr Opin Cell Biol 1998, 10:769-775
40. Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM, Shimada H, Coussens LM, Declerck YA: The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 2005, 65:3200-3208
41. Reynolds FH, Todaro GJ, Fryling C, Stephenson JR: Human transforming growth factors induce tyrosine phosphorylation of EGF receptors. Nature 1983, 292:259-262 (Pubitemid 11001846)
42. Price A, Shi Q, Morris D, Wilcox ME, Brasher PM, Rewcastle NB, Shalinsky D, Zou H, Appelt K, Johnston RN, Yong VW, Edwards D, Forsyth P: Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340. Clin Cancer Res 1999, 5:845-854
43. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2:737-744